Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsung-Hui Hu

Showing results (91-100 of 364) with videos related to

Pageof 37
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|June 24, 2018
Genetic polymorphisms of the hepatic pathways of fatty liver disease after living donor liver transplantationKing-Wah Chiu, Shigeru Goto, Toshiaki Nakano, et al.
Biomed Research International|April 25, 2018
Identification of IL-28B Genotype Modification in Hepatocytes after Living Donor Liver Transplantation by Laser Capture Microdissection and Pyrosequencing AnalysisKing-Wah Chiu, Toshiaki Nakano, Kuang-Den Chen, et al.
Transplantation|May 23, 2014
Section 13. Short-course pretransplant antiviral therapy is a feasible and effective strategy to prevent hepatitis C recurrence after liver transplantation in genotype 2 patientsChih-Che Lin, Catherine Kabiling, Chao-Long Chen, et al.
Surgery|June 15, 2007
A modification of NIH consensus criteria to better distinguish the highly lethal subset of primary localized gastrointestinal stromal tumors: a subdivision of the original high-risk group on the basis of outcomeHsuan-Ying Huang, Chien-Feng Li, Wen-Wei Huang, et al.
Hepatology International|November 21, 2023
Planning, implementing, and evaluating Hepatitis C virus elimination via collaborative community-based care cascade: age-period-cohort model for estimating demand from antecedent anti-HCV surveyTing-Yu Lin, Hsiao-Hsuan Jen, Tsung-Hui Hu, et al.
World Journal of Surgery|May 20, 2016
Comparison of Salvage Living Donor Liver Transplantation and Local Regional Therapy for Recurrent Hepatocellular CarcinomaChee-Chien Yong, Ming-Chao Tsai, Chih-Che Lin, et al.
Journal of Infection and Public Health|October 14, 2023
Long-term comparisons of the durability of 6 months versus 12 months antiviral therapy for hepatitis B after chemotherapy cessationShih-Yu Yang, Tsung-Hui Hu, Yeh-Pin Chou, et al.
The Journal of Infectious Diseases|January 29, 2019
The Incidence of Hepatitis B Surface Antigen Loss Between Hepatitis B E Antigen-Negative Noncirrhotic Patients Who Discontinued or Continued Entecavir TherapyChien-Hung Chen, Chao-Hung Hung, Jing-Houng Wang, et al.
Critical Care Medicine|April 28, 2023
ICU Bereaved Surrogates' Transition Through States of Co-Occurring Prolonged Grief Disorder, Posttraumatic Stress Disorder, and Depression SymptomsFur-Hsing Wen, Holly G Prigerson, Wen-Chi Chou, et al.
Annals of Transplantation|December 25, 2010
Influence of CYP2C19 genotypes on graft pathological findings and postoperative liver function in recipients after living-donor liver transplantationKing-Wah Chiu, Toshiaki Nakano, Tsung-Hui Hu, et al.
Pageof 37

Showing results (91-100 of 364) with videos related to

Sort By:
Pageof 37
Liver International : Official Journal of the International Association for the Study of the Liver|June 24, 2018
Genetic polymorphisms of the hepatic pathways of fatty liver disease after living donor liver transplantationKing-Wah Chiu, Shigeru Goto, Toshiaki Nakano, et al.
Biomed Research International|April 25, 2018
Identification of IL-28B Genotype Modification in Hepatocytes after Living Donor Liver Transplantation by Laser Capture Microdissection and Pyrosequencing AnalysisKing-Wah Chiu, Toshiaki Nakano, Kuang-Den Chen, et al.
Transplantation|May 23, 2014
Section 13. Short-course pretransplant antiviral therapy is a feasible and effective strategy to prevent hepatitis C recurrence after liver transplantation in genotype 2 patientsChih-Che Lin, Catherine Kabiling, Chao-Long Chen, et al.
Surgery|June 15, 2007
A modification of NIH consensus criteria to better distinguish the highly lethal subset of primary localized gastrointestinal stromal tumors: a subdivision of the original high-risk group on the basis of outcomeHsuan-Ying Huang, Chien-Feng Li, Wen-Wei Huang, et al.
Hepatology International|November 21, 2023
Planning, implementing, and evaluating Hepatitis C virus elimination via collaborative community-based care cascade: age-period-cohort model for estimating demand from antecedent anti-HCV surveyTing-Yu Lin, Hsiao-Hsuan Jen, Tsung-Hui Hu, et al.
World Journal of Surgery|May 20, 2016
Comparison of Salvage Living Donor Liver Transplantation and Local Regional Therapy for Recurrent Hepatocellular CarcinomaChee-Chien Yong, Ming-Chao Tsai, Chih-Che Lin, et al.
Journal of Infection and Public Health|October 14, 2023
Long-term comparisons of the durability of 6 months versus 12 months antiviral therapy for hepatitis B after chemotherapy cessationShih-Yu Yang, Tsung-Hui Hu, Yeh-Pin Chou, et al.
The Journal of Infectious Diseases|January 29, 2019
The Incidence of Hepatitis B Surface Antigen Loss Between Hepatitis B E Antigen-Negative Noncirrhotic Patients Who Discontinued or Continued Entecavir TherapyChien-Hung Chen, Chao-Hung Hung, Jing-Houng Wang, et al.
Critical Care Medicine|April 28, 2023
ICU Bereaved Surrogates' Transition Through States of Co-Occurring Prolonged Grief Disorder, Posttraumatic Stress Disorder, and Depression SymptomsFur-Hsing Wen, Holly G Prigerson, Wen-Chi Chou, et al.
Annals of Transplantation|December 25, 2010
Influence of CYP2C19 genotypes on graft pathological findings and postoperative liver function in recipients after living-donor liver transplantationKing-Wah Chiu, Toshiaki Nakano, Tsung-Hui Hu, et al.
Pageof 37